Life sciences covers businesses with almost nothing in common commercially: a research reagent supplier selling to academic labs, a diagnostics company selling to hospital procurement, a contract research organisation selling to pharma business development, a device manufacturer under regulatory promotional constraints, and a therapeutics company that may not be permitted to promote at all yet. Agencies use the same sector label for all of them. Before you shortlist anyone, be precise about which business you are, because that decides whether you need a technical content operation, a regulated promotional workflow, or an account based programme aimed at a few dozen named buyers.
Regulatory review sets the pace, so plan around it
If your promotional material is regulated, and for prescription products and many devices it is, the constraint is not creative capacity but the review queue. Promotional claims for prescription drugs must be consistent with the approved labelling and carry required risk information, and the FDA's own overview of prescription drug advertising is the plain summary of what that means. Practically, an agency that has never worked inside a medical, legal and regulatory review cycle will build a content calendar that assumes drafts publish within days, then spend six months explaining delays it created. Ask each candidate to describe a review workflow they have operated: who submits, in what format, with what referencing, how annotations are handled, how many rounds are typical. Agencies with real experience will talk about referencing every claim to a source document as a matter of course, because that is what makes review survivable. If you are unregulated, for example selling research use only products, you have far more latitude and should not accept the pricing premium that a regulated workflow justifies.
The audience is small, technical and hard to reach
Search volumes in this sector look catastrophic to an agency used to consumer numbers. A few dozen monthly searches for a specific assay, technique or instrument category is normal, and each of those visitors may be worth a great deal. That inverts the usual planning. Depth beats breadth: application notes, protocols, comparison pages that address the actual selection criteria a scientist uses, and content written by or with people who have run the experiment. It also means an agency must be comfortable saying that a large share of your addressable market cannot be reached through search at all and belongs to conferences, publications, field sales and account based programmes. Ask candidates how they would build a plan when the best query in the category has modest volume, and ask what proportion of the budget they would put outside search. Firms that only know how to spend on channels they manage will not raise that question themselves.
Who writes, and can they be trusted with the science
This is where most engagements fail. Content in this sector is either written by someone with a relevant scientific background, or it is written by a generalist and corrected by your scientists, which converts your most expensive people into copy editors. Ask directly whether the agency employs writers with life sciences training, whether they are staff or freelance, and ask for a piece one of them wrote alongside the sources it drew on. Then ask how they handle the boundary between what your data supports and what a marketer would like to say, since the pressure to overstate is constant and the consequences are regulatory rather than reputational. A good agency will describe having refused a claim. This is also the point where the broader question of digital marketing and SEO services becomes concrete, because the technical pages that earn search visibility here are the same pages that must survive scientific review, and they cannot be produced by a content mill at volume.
Commercial terms and how to compare quotes
Write one scope document and send it to every candidate, or quotes will not be comparable in a sector where scopes vary this widely. Ask for the disclosed minimum engagement and term, how many hours a month the retainer assumes, what is delivered in house versus subcontracted, and who is assigned to the account. Ask how they price review cycles, because an agency absorbing unlimited rounds has priced them into the rate and one billing per round will surprise you in month three. Confirm ownership of the site, the analytics property and the content, including source files for any figures or illustrations, since scientific graphics are often subcontracted and the editable files go missing. Finally, ask what business measure they expect to move and by when. Sample requests, quote requests and qualified opportunities are real. Traffic to a page about a technique is not, on its own, evidence of anything.
Questions people ask about life sciences marketing agency
Do we need an agency that specialises in life sciences?
If your promotion is regulated, strongly yes, because the review workflow is the job. If you sell research use only products to scientists, a strong technical agency with good interview discipline can do well. Test the claim of specialism by asking what specifically transfers beyond vocabulary, and judge whether the answer is concrete.
How do we handle content when the product is not approved yet?
Pre-approval promotion is restricted, so the work shifts to disease state education, corporate and pipeline communication, and scientific exchange handled by medical affairs rather than marketing. Any agency proposing product promotion before approval is a liability. Ask how they have handled a pre-launch period previously and who reviewed the material.
What is a realistic content cadence?
It is set by your review capacity and your scientists' availability, not by an agency package. Many companies sustain a small number of substantial technical pieces a month. Agree the number during selection based on real reviewer availability, and price the plan to it rather than accepting a cadence designed for a different sector.
How should the engagement be measured?
By pipeline events that your commercial team recognises: sample or demo requests, quote requests, named accounts engaging, opportunities created. Insist those appear in monthly reporting alongside traffic, and agree the reporting lag given a sales cycle that may run several quarters, so nobody judges the programme before it could possibly show.